Technology reports

The Global Proteomics Partnering Terms and Agreements 2010-2020 report provides comprehensive understanding and unprecedented access to the proetomics partnering deals and agreements entered into by the worlds leading healthcare companies.

The Global Genomics Partnering Terms and Agreements 2014-2020 report provides comprehensive understanding and unprecedented access to the genomics partnering deals and agreements entered into by the worlds leading healthcare companies.

The Global Microbiome Partnering Terms and Agreements 2010-2020 report provides comprehensive understanding and unprecedented access to the microbiome partnering deals and agreements entered into by the worlds leading healthcare companies.

The Global Biosimilars Partnering Terms and Agreements 2010-2020 report provides comprehensive understanding and unprecedented access to the biosimilars partnering deals and agreements entered into by the worlds leading healthcare companies.

Global Molecular Diagnostics Partnering Terms and Agreements 2014-20209 report provides comprehensive understanding and unprecedented access to the molecular diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.

The Global Diagnostic Imaging Partnering Terms and Agreements 2014 to 2020 report provides comprehensive understanding and unprecedented access to the diagnostic imaging partnering deals and agreements entered into by the worlds leading healthcare companies.

The Global Gene Therapy Partnering Terms and Agreements 2014-2020 report provides comprehensive understanding and unprecedented access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies.

The Global Regenerative Medicine Partnering Terms and Agreements 2014-2020 report provides comprehensive understanding and unprecedented access to the regenerative medicine including cell therapy, organ regeneration, stem cells and tissue regeneration partnering deals and agreements entered into by the worlds leading healthcare companies.

The Global Monoclonal Antibody Partnering Terms and Agreements 2014 to 2020 report provides comprehensive understanding and unprecedented access to the monoclonal antibodies partnering deals and agreements entered into by the worlds leading healthcare companies.

The All In One Partnering Intelligence Platform

Get unlimited access to our collection of partnering reports, conveniently and easily, while maximizing your time and budget